Error loading player: No playable sources found

382229

Accelerate Your Viral Vector Analytics with Automated Tools from Bio-Techne

Date
June 7, 2022
This product is not available for individual purchase, but it is available as part of the following products:
Thumbnail for Cell & Gene Therapy Products 2022
The Cell and Gene Therapy Products (CGTP) Symposium: Manufacturing, Quality and Regulatory Considerations enables the exchange of scientific ideas and dialogue with regulators that form the basis of evolving regulatory practices in the development of these diverse and innovative products…

Modern medicines call for modern technologies. Revolutionary cell and gene therapies offer significant promise to treat life-threatening diseases. Getting therapies to market quickly and efficiently requires accurate testing of critical quality attributes, including accurate viral vector analysis.

In this technical seminar, you'll learn how a variety of innovative analytical tools from Bio-Techne can help give you the automation and scalability you need on your road to discovery, along with consistent, high-quality data across labs and project phases. You'll discover how these next-generation analytical solutions are designed to easily fit into your current workflows and adapt to your changing needs.

Speaker


Related Products

Thumbnail for Session III - Current Understanding of the Product Quality Attributes that Impact Safety and Efficacy of AAV-based Gene Therapy Products
Session III - Current Understanding of the Product Quality Attributes that Impact Safety and Efficacy of AAV-based Gene Therapy Products
Adeno-associated viral (AAV) vector-based gene therapy medicinal products hold curative promise for many disease indications…
Thumbnail for Session V - Potency Assays
Session V - Potency Assays
Potency is a critical quality attribute (CQA) for cell and gene therapy (CGT) medicinal products…
Thumbnail for Session IV - Emerging Technologies
Session IV - Emerging Technologies
In recent years, cell and gene therapies have evolved rapidly into approved products for the treatment of both incurable genetic diseases as well as for the treatment of certain cancers…